Clinical utility gene card for oculocutaneous (OCA) and ocular albinism (OA)—an update

EuroGentest2 (Unit 2: “Genetic testing as part of health care”), a Coordination Action under FP7 (Grant Agreement Number 261469) and the European Society of Human Genetics. We acknowledge the support of Fight for Sight, Academy of Medical Sciences, Ulverscroft Foundation, National Institute of Health Research and Medical Research Council. MGT is supported by the NIHR (CL-2017-11-003). MGT acknowledges the support of Fight for Sight, Ulverscroft Foundation, Medical Research Council, National Institute of Health Research (CL-2017-11-003) and Academy of Medical Sciences.